SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/36AB74892AA0EBA77D857AFA99BFEAD99EF1C088E35C6F439E0921B4F6CBD726EDDB9D1A2D231D75FF897E3A7DAC9C4B>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/36AB74892AA0EBA77D857AFA99BFEAD99EF1C088E35C6F439E0921B4F6CBD726EDDB9D1A2D231D75FF897E3A7DAC9C4B
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/36AB74892AA0EBA77D857AFA99BFEAD99EF1C088E35C6F439E0921B4F6CBD726EDDB9D1A2D231D75FF897E3A7DAC9C4B
http://www.w3.org/2000/01/rdf-schema#comment
"differences in malignant cell survival effected by MAT-IIbeta ablation suggest that it may be possible to use this approach to disadvantage leukemic cell survival in vivo with little to no harm to normal cells."
xsd:string
http://purl.uniprot.org/uniprot/#_D73DA32268A4F17AA087D16EA461D30719006D9044580E1654C48539F76DFED5B9524B6ED73D8C622666F0D5DF50635D
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/36AB74892AA0EBA77D857AFA99BFEAD99EF1C088E35C6F439E0921B4F6CBD726EDDB9D1A2D231D75FF897E3A7DAC9C4B
http://purl.uniprot.org/uniprot/A0A140VJP2
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/36AB74892AA0EBA77D857AFA99BFEAD99EF1C088E35C6F439E0921B4F6CBD726EDDB9D1A2D231D75FF897E3A7DAC9C4B
http://purl.uniprot.org/uniprot/#_A0A140VJP2-mappedCitation-18753136
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/36AB74892AA0EBA77D857AFA99BFEAD99EF1C088E35C6F439E0921B4F6CBD726EDDB9D1A2D231D75FF897E3A7DAC9C4B